AIM ImmunoTech Inc. (AIM)

AIM ImmunoTech Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0.19	0.2	0.14	0.14	0.16	0.14
Revenue Growth (YoY)	23.72%	43.26%	4.44%	-17.18%	16.43%	-61.85%
Cost of Revenue	0.05	0.04	0	0.85	0.81	0.89
Gross Profit	0.14	0.16	0.14	-0.72	-0.64	-0.75
Selling, General & Admin	22.66	21.14	13.07	8.67	8.65	7.04
Research & Development	10.84	10.94	6.99	7.67	5.72	4.65
Other Operating Expenses	-0.04	-0.02	-0	1.56	0.14	0
Operating Expenses	33.46	32.06	20.06	17.91	14.51	11.69
Operating Income	-33.32	-31.9	-19.92	-18.62	-15.15	-12.44
Interest Expense / Income	0.07	0	0	0.07	0.67	0.43
Other Expense / Income	-2.27	-2.94	-0.48	0.44	-1.42	-3.47
Pretax Income	-31.12	-28.96	-19.45	-19.13	-14.4	-9.4
Net Income	-31.12	-28.96	-19.45	-19.13	-14.4	-9.4
Shares Outstanding (Basic)	49	49	48	47	32	4
Shares Outstanding (Diluted)	49	49	48	47	32	4
Shares Change	2.19%	1.12%	1.49%	48.67%	774.15%	262.71%
EPS (Basic)	-0.64	-0.60	-0.40	-0.40	-0.45	-2.58
EPS (Diluted)	-0.64	-0.60	-0.40	-0.40	-0.45	-2.58
Free Cash Flow	-22.43	-21.22	-12.29	-13.76	-10.39	-9.14
Free Cash Flow Per Share	-0.45	-0.44	-0.26	-0.29	-0.33	-2.51
Gross Margin	74.09%	79.21%	100.00%	-529.63%	-394.48%	-537.86%
Operating Margin	-17261.66%	-15791.09%	-14127.66%	-13794.07%	-9295.71%	-8887.86%
Profit Margin	-16123.32%	-14337.62%	-13790.78%	-14168.15%	-8834.36%	-6717.14%
Free Cash Flow Margin	-11623.83%	-10504.95%	-8719.15%	-10193.33%	-6374.23%	-6525.00%
EBITDA	-30.58	-28.44	-19.87	-18.29	-13	-8.19
EBITDA Margin	-15843.01%	-14077.72%	-14091.49%	-13544.44%	-7972.39%	-5846.43%
Depreciation & Amortization	0.47	0.53	-0.42	0.78	0.73	0.79
EBIT	-31.05	-28.96	-19.45	-19.06	-13.73	-8.98
EBIT Margin	-16086.01%	-14337.62%	-13790.78%	-14118.52%	-8422.09%	-6412.14%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).